8-K: Ascend Wellness Holdings Reports 15% Revenue Growth in Q2 2024, Revises Full-Year Guidance

Ascend Wellness Holdings announced a 15% year-over-year increase in net revenue for Q2 2024, reaching $141.5 million, while also revising its full-year outlook due to increased competition and wholesale profitability trends.

Summary

• Ascend Wellness Holdings (AWH) reported its financial results for the second quarter of 2024, ending June 30, 2024.
• Net revenue reached $141.5 million, a 15.1% increase year-over-year but a 0.6% decrease quarter-over-quarter.
• Adjusted EBITDA was $28.3 million, a 32.9% increase year-over-year but a 12.7% decrease quarter-over-quarter.
• The company generated approximately $32 million in cash flow from operations, marking the sixth consecutive quarter of positive operating cash flow.
• Free cash flow was approximately $27 million, or $9 million excluding state and federal tax refunds.
• AWH successfully refinanced $215 million of its existing term loan with a new Senior Secured Note facility.
• Two new dispensaries were opened in Q2 2024, bringing the total to 38 operating dispensaries.
• The company has revised its full-year guidance, now anticipating net revenue to increase between 11% and 13% and Adjusted EBITDA to increase between 5% and 10% compared to the prior year.
• Cash from Operations is now expected to be above $40 million for the full year, excluding tax refunds.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While there was strong year-over-year growth, the sequential declines, revised guidance, and net loss raise concerns. The company is taking steps to address these issues, but the overall tone is cautious.

Positives

• The company experienced significant year-over-year growth in net revenue and Adjusted EBITDA.
• AWH has maintained positive cash flow from operations for six consecutive quarters.
• The successful refinancing of the term loan provides financial flexibility.
• The opening of new dispensaries and expansion into new markets like Maryland and Ohio are positive growth indicators.
• The appointment of a new independent director strengthens corporate governance.
• Wholesale revenue showed strong year-over-year growth.

Negatives

• Net loss for the quarter was $21.8 million, compared to a net income of $0.8 million in Q2 2023.
• There was a sequential decrease in net revenue and Adjusted EBITDA compared to the previous quarter.
• Gross profit and Adjusted Gross Profit margins decreased sequentially.
• The company revised its full-year guidance downwards due to increased competition and wholesale profitability trends.
• Retail revenue decreased 2.2% quarter-over-quarter.
• Adjusted EBITDA margin decreased 278 basis points sequentially.

Risks

• Increased retail competition in select markets is impacting performance.
• Recent profitability trends in the wholesale business are a concern.
• The company's performance did not meet expectations this quarter.
• Sequential declines in retail revenue in Illinois, New Jersey, and Massachusetts are a concern.
• Declines in wholesale profitability in Massachusetts and Illinois are impacting gross profit margins.

Future Outlook

The company has revised its full-year guidance, now anticipating net revenue to increase between 11% and 13% and Adjusted EBITDA to increase between 5% and 10% for the full year 2024 compared to the prior year. Cash from Operations is now expected to be above $40 million, excluding the benefit of tax refunds.

Management Comments

• John Hartmann, CEO, stated that the company achieved robust year-over-year growth in key metrics, including a 15% increase in revenue and a 33% rise in Adjusted EBITDA.
• Hartmann also noted that the growth was driven by an increase in wholesale customers, the opening of seven retail dispensaries, and the acquisition of four dispensaries in Maryland.
• Mark Cassebaum, CFO, mentioned that while the company delivered solid growth compared to last year, performance this quarter did not meet expectations, leading to cost management and business optimization efforts.
• Cassebaum also stated that the company believes that with its strong asset base, the commencement of non-medical sales in Ohio, planned additional dispensaries, and cost actions, they can achieve significant year-over-year growth figures.

Industry Context

The cannabis industry is experiencing increased competition, which is impacting AWH's retail and wholesale performance. The company's revised guidance reflects these challenges, as well as the need to adapt to changing market dynamics. The expansion into new markets like Maryland and Ohio is a common strategy in the industry to drive growth.

Comparison to Industry Standards

• Compared to other multi-state cannabis operators, AWH's 15% year-over-year revenue growth is solid, but the sequential decline and revised guidance indicate challenges.
• Companies like Curaleaf and Green Thumb Industries have also reported strong revenue growth, but profitability remains a key focus across the industry.
• The adjusted EBITDA margin of 20% is within the range of other established operators, but the sequential decline is a concern.
• The successful refinancing of debt is a positive step, as many cannabis companies face challenges in accessing capital.
• The expansion into new markets and the focus on branded products are consistent with industry trends.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the revised guidance and net loss.
• Employees may be affected by cost management and business optimization efforts.
• Customers will benefit from the opening of new dispensaries and the availability of AWH branded products.
• Lenders and investors will be monitoring the company's performance and cash flow.

Next Steps

• The company will focus on managing costs and optimizing business functions to address the shortfall in performance.
• AWH plans to continue expanding its retail footprint with additional dispensaries.
• The company will continue to leverage its strong asset base and the commencement of non-medical sales in Ohio to drive growth.
• AWH will host a conference call on August 5, 2024, to discuss its financial results.

Key Dates

Keywords

cannabis, Ascend Wellness Holdings, AWH, financial results, net revenue, adjusted EBITDA, dispensaries, wholesale, retail, cash flow, refinancing, guidance